raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:402020

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)

Synonyms: AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)

Type
Disease
Group
Disorder
Inheritance
Not applicable
Status
active

A subtype of acute myeloid leukemia with recurrent genetic abnormalities characterized by clonal proliferation of myeloid blasts in the bone marrow, blood and, rarely, other tissues. Bone marrow typically shows small, hypolobated megakaryocytes and multilineage dysplasia. Patients typically present with leukocytosis, anemia, variable platelet counts and a variety of nonspecific symptoms related to ineffective hematopoesis (fatigue, bleeding, bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). High resistance to conventional chemotherapy is reported.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
frLeucémie myéloïde aiguë associée à inv(3)(q21q26.2) ou t(3;3)(q21;q26.2)
deAkute myeloische Leukämie mit inv3(q21q26.2) oder t(3;3)(q21;q26.2)AML mit inv3(p21;q26.2) oder t(3;3)(p21;q26.2)
esLeucemia mieloide aguda con inv(3)(q21;q26.2) o t(3;3)(q21;q26.2)LMA con inv(3)(q21;q26.2) o t(3;3)(q21;q26.2)
itLeucemia mieloide acuta con inv3(p21;q26.2) o t(3;3)(p21;q26.2)AML con inv3(p21;q26.2) o t(3;3)(p21;q26.2)
nlAcute myeloïde leukemie met inv3(q21;q26.2) of t(3;3)(q21;q26.2)AML met inv3(q21;q26.2) of t(3;3)(q21;q26.2)
ptLeucemia mielóide aguda com inv3(p21;q26.2) ou t(3;3)(p21;q26.2)
plOstra białaczka szpikowa z inv3(p21;q26.2) i t(3;3)(p21;q26.2)AML z inv3(p21;q26.2) lub t(3;3)(p21;q26.2)
csAkutní myeloidní leukémie s inv3(p21;q26.2) nebo t(3;3)(p21;q26.2)AML s inv3(p21;q26.2) nebo t(3;3)(p21;q26.2)
ukГострий мієлоїдний лейкоз з inv(3)(q21q26.2) або t(3;3)(q21;q26.2)AML з inv(3)(q21q26.2) або t(3;3)(q21;q26.2)
zh急性髓系白血病伴inv(3)(q21q26.2) or t(3;3)(q21;q26.2)变异AML伴inv(3)(q21q26.2)或t(3;3)(q21;q26.2)
trinv (3)(q21q26.2) veya t(3; 3)(q21; q26.2) ile seyreden akut miyeloid lösemiinv(3)(q21q26.2) veya t(3;3)(q21;q26.2)ile seyreden AML

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C92.0NTBTattributedvalidated
ICD-112A60.0NTBTindexvalidated
MONDO0018435Evalidated
UMLSC2826172Evalidated
GARD12759Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MECOMPart of a fusion gene inAssessedHGNC:3498ENSG000000852761652153q26.2MDS1 and EVI1 complex locus19357394[PMID]_20556821[PMID]
RPN1Part of a fusion gene inAssessedHGNC:10381ENSG000001639021804703q21.3ribophorin I19357394[PMID]_20556821[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence0.02 / 100 000WorldwideValue and classValidated36951163[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card